DEA Moves to Pull Doctor’s License Over Alleged Prescription Cover-Up
Published Date: 10/19/2026
Notice
Summary
Dr. Muhamad Aly Rifai from Easton, PA, is facing the loss of his DEA license because he allegedly faked patient records to hide illegal drug prescriptions. After delays and legal back-and-forth, the DEA is moving to revoke his registration to protect public safety. This means Dr. Rifai can no longer legally prescribe controlled substances, impacting his medical practice immediately.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 1 costs, 0 mixed.
DEA Registration Revoked for Dr. Rifai
The Drug Enforcement Administration revoked Muhamad Aly Rifai, M.D.'s DEA Certificate of Registration No. BR7552272. As a result, Dr. Rifai can no longer legally prescribe controlled substances (the Agency granted the Government's Request for Final Agency Action published October 19, 2026).
Falsified Records / Improper Prescribing Grounds for Revocation
The Agency found substantial record evidence that falsifying patient medical records and issuing controlled‑substance prescriptions without proper evaluation violated Pennsylvania rules (49 Pa. Code Sec. 16.92(a)(4); 16.95(a)) and federal regulation (21 CFR 1306.04(a)). The Decision states such conduct threatens public health and is a valid ground for DEA to revoke a practitioner's registration.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2025-05007, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
Starting December 31, 2025, veterans can get buprenorphine treatment and follow-up care through telemedicine, making it easier to access help for opioid use disorder without leaving home. This change affects veterans using VA health services and aims to improve treatment access while the government reviews feedback and policies. No new costs are mentioned, but the delay gives agencies time to ensure the rules work well.
2025-02793, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
The government is giving veterans easier access to buprenorphine treatment through telemedicine, letting them get care remotely. This change affects veterans using VA health services and aims to make treatment smoother and more convenient. The new rules were supposed to start February 18, 2025, but now they’ll kick in on March 21, 2025, while the government gathers public feedback.
2026-21413, Jefferson Burroughs, M.D.; Decision and Order
Dr. Jefferson Burroughs from Ohio lost his DEA registration to handle controlled substances because he no longer has the legal authority to prescribe them in his state. He didn’t ask for a hearing to challenge this, so the DEA officially revoked his registration as of July 31, 2026. This means Dr. Burroughs can’t legally prescribe or manage controlled drugs anymore, affecting his medical practice and patients.
2026-21414, Jan Pijanowski, M.D.; Decision and Order
Dr. Jan Pijanowski from Ohio lost his DEA registration because his medical license expired and he didn’t respond to the DEA’s notice. This means he can no longer prescribe or handle controlled substances, effective immediately. If you’re a patient or pharmacy, this change is official as of October 2026 and affects any prescriptions tied to him.
Previous / Next Documents
Previous: 2026-21257, Administrative Declaration of an Economic Injury Disaster for the State of Arizona
Arizona businesses and nonprofits near the Grand Canyon got hit by flash floods from August 29 to September 3, 2026. The government just declared an Economic Injury Disaster, opening the door for low-interest loans to help them bounce back. If you’re affected, you’ve got until July 13, 2027, to apply online and get some financial relief rolling!
Next: 2026-21259, Sunshine Act Meetings
The Federal Maritime Commission is holding a meeting on October 27, 2026, with some parts open to the public and others closed. This affects anyone interested in maritime regulations and consumer affairs, offering live streaming and recorded access for transparency. No new costs or deadlines are introduced, but security checks apply for visitors attending in person.